Human secreted tau increases amyloid-beta production

被引:179
作者
Bright, Jessica [1 ]
Hussain, Sami [2 ]
Dang, Vu [1 ]
Wright, Sarah [1 ]
Cooper, Bonnie [1 ]
Byun, Tony [2 ]
Ramos, Carla [2 ]
Singh, Andrew [2 ]
Parry, Graham [2 ]
Stagliano, Nancy [1 ,2 ]
Griswold-Prenner, Irene [1 ]
机构
[1] iPierian, Dept Discovery Biol, San Francisco, CA USA
[2] iPierian, Dept Translat Res, San Francisco, CA USA
关键词
Secreted tau; Extracellular tau; eTau; Amyloid-beta (A beta); Neuronal hyperactivity; Alzheimer's disease; Feed forward mechanism; sAPP alpha; PAIRED HELICAL FILAMENTS; PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; NEUROFIBRILLARY DEGENERATION; ENDOGENOUS TAU; PROTEIN; MOUSE; REDUCTION; TANGLES; CONFORMATION;
D O I
10.1016/j.neurobiolaging.2014.09.007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The interaction of amyloid-beta (A beta) and tau in the pathogenesis of Alzheimer's disease is a subject of intense inquiry, with the bulk of evidence indicating that changes in tau are downstream of A beta. It has been shown however, that human tau overexpression in amyloid precursor protein transgenic mice increases A beta plaque deposition. Here, we confirm that human tau increases A beta levels. To determine if the observed changes in A beta levels were because of intracellular or extracellular secreted tau (eTau for extracellular tau), we affinity purified secreted tau from Alzheimer's disease patient-derived cortical neuron conditioned media and analyzed it by liquid chromatography-mass spectrometry. We found the extracellular species to be composed predominantly of a series of N-terminal fragments of tau, with no evidence of C-terminal tau fragments. We characterized a subset of high affinity tau antibodies, each capable of engaging and neutralizing eTau. We found that neutralizing eTau reduces A beta levels in vitro in primary human cortical neurons where exogenously adding eTau increases A beta levels. In vivo, neutralizing human tau in 2 human tau transgenic models also reduced A beta levels. We show that the human tau insert sequence is sufficient to cause the observed increase in A beta levels. Our data furthermore suggest that neuronal hyperactivity may be the mechanism by which this regulation occurs. We show that neuronal hyperactivity regulates both eTau secretion and A beta production. Electrophysiological analysis shows for the first time that secreted eTau causes neuronal hyperactivity. Its induction of hyperactivity may be the mechanism by which eTau regulates A beta production. Together with previous findings, these data posit a novel connection between tau and A beta, suggesting a dynamic mechanism of positive feed forward regulation. A beta drives the disease pathway through tau, with eTau further increasing A beta levels, perpetuating a destructive cycle. (C) 2015 The Authors. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:693 / 709
页数:17
相关论文
共 41 条
[1]   Alzheimer's disease:: intraneuronal alterations precede insoluble amyloid-β formation [J].
Braak, H ;
Del Tredici, K .
NEUROBIOLOGY OF AGING, 2004, 25 (06) :713-718
[2]   STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES [J].
BRAAK, H ;
BRAAK, E .
NEUROBIOLOGY OF AGING, 1995, 16 (03) :271-278
[3]   Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid [J].
Braak, Heiko ;
Zetterberg, Henrik ;
Del Tredici, Kelly ;
Blennow, Kaj .
ACTA NEUROPATHOLOGICA, 2013, 126 (05) :631-641
[4]   A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells [J].
Burkhardt, Matthew F. ;
Martinez, Fernando J. ;
Wright, Sarah ;
Ramos, Carla ;
Volfson, Dmitri ;
Mason, Michael ;
Garnes, Jeff ;
Vu Dang ;
Lievers, Jeffery ;
Shoukat-Mumtaz, Uzma ;
Martinez, Rita ;
Gai, Hui ;
Blake, Robert ;
Vaisberg, Eugeni ;
Grskovic, Marica ;
Johnson, Charles ;
Irion, Stefan ;
Bright, Jessica ;
Cooper, Bonnie ;
Leane Nguyen ;
Griswold-Prenner, Irene ;
Javaherian, Ashkan .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 56 :355-364
[5]   Constitutive secretion of tau protein by an unconventional mechanism [J].
Chai, Xiyun ;
Dage, Jeffrey L. ;
Citron, Martin .
NEUROBIOLOGY OF DISEASE, 2012, 48 (03) :356-366
[6]   Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling [J].
Chambers, Stuart M. ;
Fasano, Christopher A. ;
Papapetrou, Eirini P. ;
Tomishima, Mark ;
Sadelain, Michel ;
Studer, Lorenz .
NATURE BIOTECHNOLOGY, 2009, 27 (03) :275-280
[7]   Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo [J].
Cirrito, John R. ;
Kang, Jae-Eun ;
Lee, Jiyeon ;
Stewart, Floy R. ;
Verges, Deborah K. ;
Silverio, Luz M. ;
Bu, Guojun ;
Mennerick, Steven ;
Holtzman, David M. .
NEURON, 2008, 58 (01) :42-51
[8]   Synaptic activity regulates interstitial fluid amyloid-β levels in vivo [J].
Cirrito, JR ;
Yamada, KA ;
Finn, MB ;
Sloviter, RS ;
Bales, KR ;
May, PC ;
Schoepp, DD ;
Paul, SM ;
Mennerick, S ;
Holtzman, DM .
NEURON, 2005, 48 (06) :913-922
[9]   Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines [J].
Colombo, Alessio ;
Wang, Huanhuan ;
Kuhn, Peer-Hendrik ;
Page, Richard ;
Kremmer, Elisabeth ;
Dempsey, Peter J. ;
Crawford, Howard C. ;
Lichtenthaler, Stefan F. .
NEUROBIOLOGY OF DISEASE, 2013, 49 :137-147
[10]   Propagation of Tau Pathology in a Model of Early Alzheimer's Disease [J].
de Calignon, Alix ;
Polydoro, Manuela ;
Suarez-Calvet, Marc ;
William, Christopher ;
Adamowicz, David H. ;
Kopeikina, Kathy J. ;
Pitstick, Rose ;
Sahara, Naruhiko ;
Ashe, Karen H. ;
Carlson, George A. ;
Spires-Jones, Tara L. ;
Hyman, Bradley T. .
NEURON, 2012, 73 (04) :685-697